547 related articles for article (PubMed ID: 26945884)
1. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
[TBL] [Abstract][Full Text] [Related]
2. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
5. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
6. Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study.
d'Orsi G; Martino T; Lalla A; Claudio MTD; Carapelle E; Avolio C
Epileptic Disord; 2018 Dec; 20(6):525-529. PubMed ID: 30530418
[TBL] [Abstract][Full Text] [Related]
7. Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.
Szots M; Marton A; Kover F; Kiss T; Berki T; Nagy F; Illes Z
J Neurol Sci; 2014 Aug; 343(1-2):198-202. PubMed ID: 24928080
[TBL] [Abstract][Full Text] [Related]
8. Faciobrachial motor seizures: A more apt description?
Muthusamy S; Foroush NC; Seneviratne U
Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
[TBL] [Abstract][Full Text] [Related]
9. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
11. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
12. Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Zhao X; Zhao S; Chen Y; Zhang Z; Li X; Liu X; Lv R; Wang Q; Ai L
Front Immunol; 2021; 12():672846. PubMed ID: 34616389
[TBL] [Abstract][Full Text] [Related]
13. Kv1.1 channels inhibition in the rat motor cortex recapitulates seizures associated with anti-LGI1 encephalitis.
Baudin P; Whitmarsh S; Cousyn L; Roussel D; Lecas S; Lehongre K; Charpier S; Mahon S; Navarro V
Prog Neurobiol; 2022 Jun; 213():102262. PubMed ID: 35283238
[TBL] [Abstract][Full Text] [Related]
14. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
[TBL] [Abstract][Full Text] [Related]
16. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Epilepsy.
Gaspard N
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
[TBL] [Abstract][Full Text] [Related]
19. Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere.
Rachdi A; Dupouy J; Benaiteau M; Bost C; Moreau MS; Courbon CB; Rascol O; Magne FO
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656690
[TBL] [Abstract][Full Text] [Related]
20. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]